Description

Product details

Product Name: ST GLIPTIN 3D 500 Composition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg ST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action. This triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes. Product Description ST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation: Sitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner. Pioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively. Metformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake. By combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency. Uses of ST GLIPTIN 3D 500 ST GLIPTIN 3D 500 is primarily indicated for: Management of Type 2 Diabetes Mellitus Improving glycemic control in adults Patients inadequately controlled on metformin alone Individuals requiring triple oral therapy Reducing fasting and postprandial blood glucose levels Supporting long-term HbA1c reduction It is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management. How ST GLIPTIN 3D 500 Works Type 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects: Enhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia. Improves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin. Reduces glucose production (Metformin) – Decreases sugar release from the liver. This comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control. Key Benefits of ST GLIPTIN 3D 500 1. Triple Mechanism Advantage Combines three different classes of antidiabetic agents for broader and more effective blood sugar management. 2. Improved HbA1c Reduction Helps significantly lower HbA1c levels when compared to monotherapy. 3. Reduced Pill Burden Three medications in one tablet improve patient compliance and convenience. 4. Better Postprandial Control Helps manage blood glucose spikes after meals. 5. Insulin Sensitivity Enhancement Pioglitazone improves peripheral glucose utilization. 6. Lower Risk of Hypoglycemia Sitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately. 7. Suitable for Long-Term Management Designed for chronic use under medical supervision. Dosage and Administration The dosage should be taken strictly as prescribed by a healthcare professional. Usually administered once daily with meals to reduce gastrointestinal discomfort. Swallow the tablet whole with water. Do not crush or chew unless directed by a doctor. Regular monitoring of blood glucose and HbA1c levels is recommended during therapy. Possible Side Effects Like all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them. Common Side Effects: Nausea Diarrhea Stomach discomfort Headache Upper respiratory symptoms Less Common but Important: Weight gain (associated with Pioglitazone) Fluid retention or edema Low blood sugar (when combined with other antidiabetic agents) Vitamin B12 deficiency (long-term Metformin use) Rare but Serious: Lactic acidosis (rare, associated with Metformin) Pancreatitis (rare, associated with Sitagliptin) Liver function abnormalities Patients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties. Precautions and Warnings Not recommended for Type 1 diabetes. Use cautiously in patients with renal impairment. Liver function monitoring may be required. Avoid excessive alcohol consumption. Inform your doctor about any existing heart conditions. Pregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional. Storage Instructions Store below 25°C in a dry place. Keep away from direct sunlight. Keep out of reach of children. Why Choose ST GLIPTIN 3D 500? ST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden. The triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes. Conclusion ST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.

Other Specifications